HFS
HELP

Hantz Financial Services’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Hantz Financial Services’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed – – 1092
2024
Q2 		$0 Hold
1
– – ﹤0.01% 1089
2024
Q1 		$0 Hold
1
– – ﹤0.01% 1211
2023
Q4 		$0 Hold
1
– – ﹤0.01% 1136
2023
Q3 		$0 Hold
1
– – ﹤0.01% 1123
2023
Q2 		$0 Hold
1
– – ﹤0.01% 1097
2023
Q1 		$0 Hold
1
– – ﹤0.01% 1122
2022
Q4 		$0 Hold
1
– – ﹤0.01% 1091
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1084
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1049
2022
Q1 		$0 Buy
+1
New +$37 ﹤0.01% 1049

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Hantz Financial Services's HELP Position: Q3 2024 in Review

Hantz Financial Services sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 1 share.

Hantz Financial Services first reported a position in HELP in Q1 2022 and held it in 10 quarters. The position peaked at $0 in Q2 2024. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Hantz Financial Services reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Hantz Financial Services sold 1 Helus Pharma Inc. Common Stock share in Q3 2024.
  • Hantz Financial Services first reported a position in Helus Pharma Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • Hantz Financial Services's Helus Pharma Inc. Common Stock position peaked at $0 in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Hantz Financial Services's 13F filing for Q3 2024, filed 14 Nov 2024.